MCW	O	O
1820231	O	O
HEMOPTYSIS	O	O
,	O	O
H/O	O	O
RUL	O	O
LESION	O	O
,	O	O
BREAST	O	O
CA	O	O
HISTORY	O	O
OF	O	O
MYELODYSPLASTIC	O	O
DISEASE	O	O
CT	O	O
THORAX	O	O
,	O	O
CT	O	O
LIVER/SPLEEN	O	O
&	O	O
CT	O	O
PELVIS	O	O
-LRB-	O	O
#	O	O
452A	O	O
,	O	O
450A	O	O
&	O	O
451A	O	O
-RRB-	O	O
TECHNIQUE	O	O
:	O	O
2.5	O	O
MM	O	O
AXIAL	O	O
COMPUTED	O	O
TOMOGRAPHIC	O	O
IMAGES	O	O
WERE	O	O
OBTAINED	O	O
THROUGH	O	O
THE	O	O
CHEST	O	O
,	O	O
ABDOMEN	O	O
AND	O	O
PELVIS	O	O
AFTER	O	O
THE	O	O
ADMINISTRATION	O	O
OF	O	O
ORAL	O	O
AND	O	O
131	O	O
CC	O	O
OF	O	O
INTRAVENOUS	O	O
OMNIPAQUE	O	O
300	O	O
.	O	O
COMPARISON	O	O
:	O	O
-LSB-	O	O
date	O	O
-RSB-	O	O
.	O	O
FINDINGS	O	O
:	O	O
AS	O	O
SEEN	O	O
ON	O	O
THE	O	O
PRIOR	O	O
EXAMINATION	O	O
,	O	O
AN	O	O
ANTERIOR	O	O
SEGMENT	O	O
RIGHT	1_Red_Minutes	O
UPPER	1_Red_Minutes	O
LOBE	1_Red_Minutes	O
MASS	1_Red_Minutes	O
IS	O	O
IDENTIFIED	O	O
AT	O	O
THE	O	O
JUNCTION	O	O
OF	O	O
THE	O	O
SUPERIOR	O	O
VENA	O	O
CAVA	O	O
AND	O	O
LEFT	O	O
INNOMINATE	O	O
VEIN	O	O
.	O	O
IT	O	O
MEASURES	O	O
3.6	O	O
CM	O	O
X	O	O
2.2	O	O
CM	O	O
IN	O	O
DIMENSION	O	O
.	O	O
COMPARED	O	O
TO	O	O
A	O	O
SIMILAR	O	O
LOCATION	O	O
,	O	O
THIS	O	O
MASS	O	O
MEASURED	O	O
3.9	O	O
MM	O	O
X	O	O
2.6	O	O
MM	O	O
IN	O	O
DIMENSION	O	O
ON	O	O
THE	O	O
PRIOR	O	O
EXAM	O	O
.	O	O
THERE	O	O
IS	O	O
LARGE	1_Red_Minutes	O
CENTRAL	1_Red_Minutes	O
HYPOATTENUATING	O	O
COMPONENT	O	O
SUGGESTING	O	O
NECROSIS	1_Red_Minutes	1_Red_Minutes
WHICH	O	O
HAS	O	O
INCREASED	O	O
IN	O	O
COMPARISON	O	O
TO	O	O
THE	O	O
PRIOR	O	O
EXAMINATION	O	O
.	O	O
THERE	O	O
IS	O	O
PERIPHERAL	O	O
ENHANCEMENT	O	O
.	O	O
THERE	O	O
IS	O	O
ADJACENT	O	O
MINIMAL	O	O
ATELECTASIS	O	O
OF	O	O
THE	O	O
ANTERIOR	O	O
RIGHT	O	O
UPPER	O	1_Red_Minutes
LOBE	O	1_Red_Minutes
.	O	O
OTHERWISE	O	O
,	O	O
NO	O	O
ADDITIONAL	O	O
PULMONARY	O	O
NODULES	O	O
ARE	O	O
IDENTIFIED	O	O
.	O	O
THERE	O	O
IS	O	O
MOTION	O	O
ARTIFACT	O	O
,	O	O
ESPECIALLY	O	O
AT	O	O
THE	O	O
LUNG	O	O
BASES	O	O
.	O	O
NO	O	O
MEDIASTINAL	O	O
,	O	O
HILAR	O	O
OR	O	O
AXILLARY	O	O
LYMPHADENOPATHY	O	O
IS	O	O
SEEN	O	O
.	O	O
THE	O	O
PATIENT	O	O
HAS	O	O
HAD	O	O
BILATERAL	O	O
MASTECTOMIES	O	O
.	O	O
NO	O	O
INTERNAL	O	O
MAMMARY	O	O
LYMPHADENOPATHY	O	O
IS	O	O
SEEN	O	O
.	O	O
THERE	O	O
ARE	O	O
SUBTLE	O	O
AREAS	O	O
OF	O	O
LOW	O	O
ATTENUATION	O	O
WITHIN	O	O
THE	O	O
RIGHT	O	3_Yellow_Days
THYROID	O	3_Yellow_Days
GLAND	O	3_Yellow_Days
,	O	3_Yellow_Days
WHICH	O	3_Yellow_Days
MAY	O	3_Yellow_Days
REPRESENT	O	3_Yellow_Days
SMALL	O	3_Yellow_Days
NODULES	O	3_Yellow_Days
.	O	O
AS	O	O
SEEN	O	O
ON	O	O
THE	O	O
PRIOR	O	O
EXAMINATION	O	O
,	O	O
AGAIN	O	O
IDENTIFIED	O	O
IS	O	O
A	O	O
PLEURAL	O	O
-	O	O
BASED	O	O
LINEAR	O	O
AREA	O	O
OF	O	O
THICKENING	O	3_Yellow_Days
MEASURING	O	O
APPROXIMATELY	O	O
5	O	O
MM	O	O
IN	O	O
SIZE	O	3_Yellow_Days
IN	O	3_Yellow_Days
THE	O	3_Yellow_Days
LEFT	O	3_Yellow_Days
APEX	O	3_Yellow_Days
,	O	O
WHICH	O	O
REMAINS	O	O
UNCHANGED	O	O
.	O	O
AS	O	O
SEEN	O	O
ON	O	O
THE	O	O
PRIOR	O	O
EXAMINATION	O	O
,	O	O
EVALUATION	O	O
OF	O	O
THE	O	O
LIVER	O	O
AGAIN	O	O
DEMONSTRATES	O	O
A	O	O
2.3	O	O
CM	O	O
X	O	O
1.7	O	O
CM	O	O
LOW-ATTENUATION	O	O
LESION	O	O
IN	O	O
SEGMENT	O	O
2	O	O
,	O	O
WHICH	O	O
TAKEN	O	O
INTO	O	O
ACCOUNT	O	O
DIFFERENCES	O	O
IN	O	O
TECHNIQUE	O	O
,	O	O
DEMONSTRATES	O	O
NO	O	O
SIGNIFICANT	O	O
INTERVAL	O	O
CHANGE	O	O
.	O	O
ALSO	O	O
IDENTIFIED	O	O
IS	O	O
A	O	O
LOW-ATTENUATION	O	O
IN	O	O
SEGMENT	O	O
3	O	O
OF	O	O
THE	O	O
LIVER	O	O
MEASURING	O	O
APPROXIMATELY	O	O
15	O	O
MM	O	O
IN	O	O
SIZE	O	O
,	O	O
WHICH	O	O
DEMONSTRATES	O	O
NO	O	O
SIGNIFICANT	O	O
INTERVAL	O	O
CHANGE	O	O
.	O	O
BOTH	3_Yellow_Days	O
THESE	3_Yellow_Days	O
LESIONS	3_Yellow_Days	O
ARE	3_Yellow_Days	O
PRESUMED	3_Yellow_Days	O
TO	3_Yellow_Days	O
BE	3_Yellow_Days	O
HEPATIC	3_Yellow_Days	O
CYSTS	3_Yellow_Days	O
.	O	O
A	O	O
SMALLER	3_Yellow_Days	O
LOW-ATTENUATION	3_Yellow_Days	O
LESION	3_Yellow_Days	O
IS	3_Yellow_Days	O
IDENTIFIED	3_Yellow_Days	O
NEAR	3_Yellow_Days	O
THE	3_Yellow_Days	O
DOME	3_Yellow_Days	O
,	3_Yellow_Days	O
WHICH	3_Yellow_Days	O
IS	3_Yellow_Days	O
TOO	3_Yellow_Days	O
SMALL	3_Yellow_Days	O
TO	3_Yellow_Days	O
CHARACTERIZE	3_Yellow_Days	O
SEEN	O	O
ON	O	O
IMAGE	O	O
#	O	O
85	O	O
,	O	O
SERIES	O	O
3	O	O
,	O	O
WHICH	O	O
MAY	O	O
ALSO	O	O
REPRESENT	O	O
A	O	O
SMALL	O	O
CYST	O	O
.	O	O
NO	3_Yellow_Days	O
NEW	3_Yellow_Days	O
HEPATIC	3_Yellow_Days	O
LESIONS	3_Yellow_Days	O
ARE	O	O
SEEN	O	O
.	O	O
WITHIN	O	O
THE	O	O
SPLEEN	O	O
,	O	O
THERE	O	O
IS	O	O
A	O	O
SUBTLE	O	O
AREA	O	O
OF	O	O
LOW-ATTENUATION	O	O
SEEN	O	O
ON	O	O
A	O	O
PRIOR	O	O
ABDOMEN/PELVIS	O	O
CT	O	O
DATED	O	O
-LSB-	O	O
date	O	O
-RSB-	O	O
WITHIN	O	O
THE	O	O
SPLEEN	O	O
,	O	O
WHICH	O	O
AGAIN	O	O
MOST	O	O
LIKELY	O	O
REPRESENTS	O	O
A	O	O
SMALL	O	O
HEMANGIOMA	O	O
AND	O	O
MEASURES	O	O
APPROXIMATELY	O	O
2.7	O	O
MM	O	O
IN	O	O
SIZE	O	O
.	O	O
OTHERWISE	O	O
,	O	O
THE	O	O
SPLEEN	O	O
IS	O	O
UNREMARKABLE	O	O
.	O	O
THE	O	O
BILATERAL	O	O
ADRENAL	O	O
GLANDS	O	O
AND	O	O
KIDNEYS	O	O
ARE	O	O
OTHERWISE	O	O
UNREMARKABLE	O	O
.	O	O
AN	O	O
EXTRARENAL	O	O
PELVIS	O	O
IS	O	O
SEEN	O	O
ON	O	O
THE	O	O
RIGHT	O	O
.	O	O
INCIDENTALLY	O	O
NOTED	O	O
,	O	O
IS	O	O
A	O	O
RETROAORTIC	O	O
LEFT	O	O
RENAL	O	O
VEIN	O	O
.	O	O
THERE	O	O
IS	O	O
NO	O	O
RETROPERITONEAL	O	O
LYMPHADENOPATHY	O	O
.	O	O
THE	O	O
PATIENT	O	O
IS	O	O
STATUS	O	O
POST	O	O
HYSTERECTOMY	O	O
.	O	O
SMALL	3_Yellow_Days	O
AMOUNT	3_Yellow_Days	O
OF	3_Yellow_Days	O
FREE	3_Yellow_Days	O
FLUID	3_Yellow_Days	O
IS	3_Yellow_Days	O
NOTED	3_Yellow_Days	O
WITHIN	3_Yellow_Days	O
THE	3_Yellow_Days	O
PELVIS	3_Yellow_Days	O
.	O	O
THIS	3_Yellow_Days	O
IS	3_Yellow_Days	O
NEW	3_Yellow_Days	O
IN	O	O
COMPARISON	O	O
TO	O	O
-LSB-	O	O
date	O	O
-RSB-	O	O
.	O	O
NO	O	O
ANEURYSMAL	O	O
DILATATION	O	O
OF	O	O
THE	O	O
ABDOMINAL	O	O
AORTA	O	O
IS	O	O
SEEN	O	O
.	O	O
DELAYED	O	O
IMAGING	O	O
THROUGH	O	O
THE	O	O
URINARY	O	O
BLADDER	O	O
DEMONSTRATES	O	O
NO	O	O
OBVIOUS	O	O
FILLING	O	O
DEFECTS	O	O
.	O	O
EVALUATION	O	O
OF	O	O
THE	O	O
BONY	O	O
WINDOWS	O	O
DEMONSTRATES	O	O
MULTILEVEL	O	O
DEGENERATIVE	O	O
DISC	O	O
DISEASE	O	O
.	O	O
A	O	O
NEW	O	O
SMALL	O	3_Yellow_Days
RIGHT	O	3_Yellow_Days
PLEURAL	O	3_Yellow_Days
EFFUSION	O	3_Yellow_Days
IS	O	O
SEEN	O	O
.	O	O
1	O	O
.	O	O
SLIGHT	1_Red_Minutes	3_Yellow_Days
INTERVAL	1_Red_Minutes	3_Yellow_Days
DECREASE	1_Red_Minutes	3_Yellow_Days
IN	1_Red_Minutes	3_Yellow_Days
SIZE	1_Red_Minutes	3_Yellow_Days
IN	O	O
AN	O	O
ANTERIOR	O	O
SEGMENT	O	O
RIGHT	1_Red_Minutes	1_Red_Minutes
UPPER	1_Red_Minutes	1_Red_Minutes
LOBE	1_Red_Minutes	1_Red_Minutes
MASS	1_Red_Minutes	1_Red_Minutes
,	1_Red_Minutes	O
NOW	O	O
MEASURING	O	O
3.6	O	O
CM	O	O
X	O	O
2.2	O	O
CM	O	O
IN	O	O
COMPARISON	O	O
TO	O	O
3.9	O	O
CM	O	O
X	O	O
2.6	O	O
CM	O	O
IN	O	O
SIZE	O	O
.	O	O
THERE	O	O
HAS	O	O
BEEN	O	O
INTERVAL	1_Red_Minutes	O
DEVELOPMENT	1_Red_Minutes	O
OF	1_Red_Minutes	O
CENTRAL	1_Red_Minutes	O
NECROSIS	1_Red_Minutes	O
.	O	O
THERE	O	O
IS	O	O
ADJACENT	O	O
ATELECTASIS	O	O
TO	O	O
THIS	O	O
REGION	O	O
.	O	O
2	O	O
.	O	O
NO	3_Yellow_Days	O
SIGNIFICANT	3_Yellow_Days	O
INTERVAL	3_Yellow_Days	O
CHANGE	3_Yellow_Days	O
IN	3_Yellow_Days	O
SMALL	3_Yellow_Days	O
5	3_Yellow_Days	O
MM	3_Yellow_Days	O
NODULAR	3_Yellow_Days	O
LESION	3_Yellow_Days	O
IN	3_Yellow_Days	O
THE	3_Yellow_Days	O
LEFT	3_Yellow_Days	O
APEX	3_Yellow_Days	O
.	O	O
NO	O	O
NEW	O	O
NODULES	O	O
ARE	O	O
IDENTIFIED	O	O
.	O	O
3	O	O
.	O	O
NEW	3_Yellow_Days	3_Yellow_Days
SMALL	3_Yellow_Days	3_Yellow_Days
RIGHT	3_Yellow_Days	3_Yellow_Days
PLEURAL	3_Yellow_Days	3_Yellow_Days
EFFUSION	3_Yellow_Days	3_Yellow_Days
.	O	O
4	O	O
.	O	O
NO	O	O
SIGNIFICANT	O	O
INTERVAL	O	O
CHANGE	O	O
IN	O	O
SEGMENT	O	O
2	O	O
AND	O	O
3	O	O
HEPATIC	O	O
CYSTS	O	O
.	O	O
5	O	O
.	O	O
INTERVAL	3_Yellow_Days	O
DEVELOPMENT	3_Yellow_Days	O
OF	3_Yellow_Days	O
A	3_Yellow_Days	O
SMALL	3_Yellow_Days	1_Red_Minutes
AMOUNT	3_Yellow_Days	1_Red_Minutes
OF	3_Yellow_Days	1_Red_Minutes
FREE	3_Yellow_Days	1_Red_Minutes
FLUID	3_Yellow_Days	1_Red_Minutes
IN	3_Yellow_Days	1_Red_Minutes
THE	3_Yellow_Days	1_Red_Minutes
PELVIS	3_Yellow_Days	1_Red_Minutes
,	O	O
CLINICAL	3_Yellow_Days	1_Red_Minutes
CORRELATION	3_Yellow_Days	1_Red_Minutes
RECOMMENDED	3_Yellow_Days	1_Red_Minutes
.	O	O
+	O	O
EXAMINATION	O	O
REVIEWED	O	O
&	O	O
REPORTED	O	O
FINDINGS	O	O
CONFIRMED	O	O
BY	O	O
:	O	O
-LSB-	O	O
doctor	O	O
-RSB-	O	O
.	O	O
71250	O	O
CT	O	O
CHEST	O	O
wo	O	O
CT	O	O
05/10/2007	O	O
ES	O	O
>	O	O
<	O	O
REPONonenhanced	O	O
chest	O	O
CT	O	O
shows	O	O
bilateral	O	O
pleural	O	O
plaques	O	O
some	O	O
of	O	O
which	O	O
are	O	O
calcified	O	O
suggesting	O	O
prior	O	O
asbestos	O	O
exposure	O	O
.	O	O
Small	3_Yellow_Days	3_Yellow_Days
right	3_Yellow_Days	3_Yellow_Days
pleural	3_Yellow_Days	3_Yellow_Days
effusion	3_Yellow_Days	3_Yellow_Days
.	O	O
Mass-like	O	O
area	O	O
of	O	O
consolidation	O	O
in	O	O
the	O	O
base	O	O
of	O	O
the	O	O
right	3_Yellow_Days	O
lower	3_Yellow_Days	O
lobe	3_Yellow_Days	O
medially	O	O
most	O	O
likely	O	O
represents	O	O
roundedatelectasis	3_Yellow_Days	O
.	O	O
Recommend	3_Yellow_Days	O
follow-up	3_Yellow_Days	O
chest	O	O
CT	O	O
in	3_Yellow_Days	O
six	3_Yellow_Days	O
months	3_Yellow_Days	O
to	3_Yellow_Days	O
a	3_Yellow_Days	O
year	3_Yellow_Days	O
to	O	3_Yellow_Days
ensure	O	3_Yellow_Days
stability	O	3_Yellow_Days
.	O	O
No	O	O
other	O	O
pulmonary	O	O
nodules	O	O
or	O	O
lymphadenopathy	O	O
.	O	O
Focal	O	3_Yellow_Days
area	O	3_Yellow_Days
of	O	3_Yellow_Days
fibrosis	O	3_Yellow_Days
in	O	3_Yellow_Days
the	O	3_Yellow_Days
base	O	3_Yellow_Days
of	O	3_Yellow_Days
the	O	3_Yellow_Days
right	O	3_Yellow_Days
middle	O	3_Yellow_Days
lobe	O	3_Yellow_Days
with	O	O
associated	O	O
mild	O	O
traction	O	O
bronchiectasis	O	O
.	O	O
Vascular	O	O
including	O	O
coronary	3_Yellow_Days	3_Yellow_Days
artery	3_Yellow_Days	3_Yellow_Days
calcifications	3_Yellow_Days	3_Yellow_Days
.	O	O
Multiple	O	3_Yellow_Days
bilateral	O	3_Yellow_Days
low	O	3_Yellow_Days
density	O	3_Yellow_Days
lesions	O	O
in	O	O
the	O	O
kidneys	O	O
most	O	O
likely	O	O
represent	O	O
cysts	O	O
.	O	O
Ultrasound	O	O
would	O	O
be	O	O
useful	O	O
for	O	O
further	O	O
evaluation	O	O
.	O	O
Bilateral	O	O
gynecomastia	O	O
.	O	O
301312277	O	O
535192	O	O
IMGCTT	O	O
CT	O	O
THORAX	O	O
CT	O	O
CHEST	O	O
:	O	O
04/04/2002	O	O
.	O	O
CLINICAL	O	O
DATA	O	O
:	O	O
Status	O	O
post	O	O
double	O	O
lung	O	O
transplant	O	O
with	O	O
pulmonary	O	O
aspergillosis	O	O
,	O	O
follow-up	O	O
centrilobular	O	O
nodular	O	O
.	O	O
FINDINGS	O	O
:	O	O
Since	O	O
the	O	O
previous	O	O
exam	O	O
dated	O	O
02/05/2002	O	O
,	O	O
there	O	O
has	O	O
been	O	O
interval	3_Yellow_Days	O
improvement	3_Yellow_Days	O
though	3_Yellow_Days	O
persistence	3_Yellow_Days	O
of	3_Yellow_Days	O
centrilobular	3_Yellow_Days	O
nodularity	3_Yellow_Days	O
involving	3_Yellow_Days	O
the	3_Yellow_Days	O
right	3_Yellow_Days	3_Yellow_Days
middle	3_Yellow_Days	3_Yellow_Days
lobe	3_Yellow_Days	3_Yellow_Days
and	3_Yellow_Days	O
bilateral	3_Yellow_Days	O
lower	3_Yellow_Days	O
lobes	3_Yellow_Days	O
.	O	O
There	O	O
is	O	O
now	O	O
minimal	3_Yellow_Days	O
centrilobular	3_Yellow_Days	O
nodularity	3_Yellow_Days	O
with	O	O
no	O	O
new	O	O
areas	O	O
of	O	O
focal	O	O
consolidation	O	O
.	O	O
Stable	O	O
scarring	O	O
is	O	O
seen	O	O
at	O	O
the	O	O
bases	O	O
.	O	O
There	O	O
is	O	O
no	O	O
axillary	O	O
,	O	O
hilar	O	O
,	O	O
or	O	O
mediastinal	O	O
lymphadenopathy	O	O
.	O	O
No	O	O
pleural	O	O
or	O	O
pericardial	O	O
effusion	O	O
is	O	O
appreciated	O	O
.	O	O
Enlarged	3_Yellow_Days	3_Yellow_Days
main	3_Yellow_Days	3_Yellow_Days
pulmonary	3_Yellow_Days	3_Yellow_Days
artery	3_Yellow_Days	3_Yellow_Days
is	O	O
again	3_Yellow_Days	O
noted	3_Yellow_Days	O
,	O	O
consistent	O	O
with	O	O
pulmonary	3_Yellow_Days	O
arterial	3_Yellow_Days	O
hypertension	3_Yellow_Days	O
.	O	O
IMPRESSION	O	O
:	O	O
1	O	O
.	O	O
MARKED	3_Yellow_Days	O
IMPROVEMENT	3_Yellow_Days	O
WITH	3_Yellow_Days	O
MILD	3_Yellow_Days	3_Yellow_Days
PERSISTENCE	3_Yellow_Days	3_Yellow_Days
OF	3_Yellow_Days	3_Yellow_Days
CENTRILOBULAR	3_Yellow_Days	3_Yellow_Days
NODULARITY	3_Yellow_Days	3_Yellow_Days
PRIMARILY	3_Yellow_Days	3_Yellow_Days
IN	3_Yellow_Days	3_Yellow_Days
THE	3_Yellow_Days	3_Yellow_Days
BILATERAL	3_Yellow_Days	3_Yellow_Days
LOWER	3_Yellow_Days	3_Yellow_Days
LOBES	3_Yellow_Days	3_Yellow_Days
WITH	O	O
NO	O	O
NEW	O	O
AREAS	O	O
OF	O	O
FOCAL	O	1_Red_Minutes
CONSOLIDATION	O	1_Red_Minutes
.	O	O
2	O	O
.	O	O
PULMONARY	3_Yellow_Days	3_Yellow_Days
ARTERIAL	3_Yellow_Days	3_Yellow_Days
HYPERTENSION	3_Yellow_Days	3_Yellow_Days
.	O	O
END	O	O
OF	O	O
IMPRESSION	O	O
:	O	O
008.8	O	O
078.5	O	O
117.3	O	O
275.2	O	O
275.41	O	O
276.8	O	O
285.1	O	O
285.9	O	O
300.00	O	O
401.9	O	O
MCW	O	O
1820463	O	O
PE	O	O
PROTOCOL	O	O
CT	O	O
THORAX	O	O
AND	O	O
CT	O	O
PELVIS	O	O
-	O	O
PE	O	O
PROTOCOL	O	O
-LRB-	O	O
#	O	O
569B-C	O	O
-RRB-	O	O
TECHNIQUE	O	O
:	O	O
HELICAL	O	O
CT	O	O
OF	O	O
THE	O	O
CHEST	O	O
WAS	O	O
PERFORMED	O	O
FOLLOWING	O	O
THE	O	O
ADMINISTRATION	O	O
OF	O	O
145	O	O
ML	O	O
OF	O	O
OMNIPAQUE	O	O
350	O	O
.	O	O
1.25	O	O
MM	O	O
AXIAL	O	O
IMAGES	O	O
AND	O	O
1.3	O	O
MM	O	O
CORONAL	O	O
SAGITTAL	O	O
IMAGES	O	O
WERE	O	O
REVIEWED	O	O
.	O	O
DELAYED	O	O
NON	O	O
-	O	O
CONTIGUOUS	O	O
AXIAL	O	O
IMAGES	O	O
THROUGH	O	O
THE	O	O
UPPER	O	O
PORTION	O	O
OF	O	O
THE	O	O
LOWER	O	O
EXTREMITIES	O	O
WERE	O	O
LATER	O	O
ACQUIRED	O	O
.	O	O
COMPARISON	O	O
:	O	O
CT	O	O
CHEST	O	O
WITHOUT	O	O
CONTRAST	O	O
DATED	O	O
-LSB-	O	O
date	O	O
-RSB-	O	O
.	O	O
THE	O	O
OPACIFICATION	O	O
OF	O	O
THE	O	O
PULMONARY	O	O
VESSELS	O	O
IS	O	O
ADEQUATE	O	O
.	O	O
THERE	O	O
IS	O	O
NO	O	O
EVIDENCE	O	O
OF	O	O
ACUTE	O	O
OR	O	O
CHRONIC	O	O
PULMONARY	O	O
EMBOLISM	O	O
.	O	O
THE	O	O
HEART	3_Yellow_Days	3_Yellow_Days
REMAINS	3_Yellow_Days	3_Yellow_Days
DIFFUSELY	3_Yellow_Days	3_Yellow_Days
ENLARGED	3_Yellow_Days	3_Yellow_Days
,	O	O
PARTICULARLY	O	O
THE	O	O
LEFT	O	O
ATRIUM	O	O
.	O	O
THE	O	O
MAIN	O	O
PULMONARY	O	O
ARTERY	O	O
IS	O	O
NORMAL	O	O
IN	O	O
CALIBER	O	O
.	O	O
THERE	O	O
IS	O	O
DIFFUSE	3_Yellow_Days	3_Yellow_Days
CORONARY	3_Yellow_Days	3_Yellow_Days
ARTERY	3_Yellow_Days	3_Yellow_Days
CALCIFIED	3_Yellow_Days	3_Yellow_Days
ATHEROMATOSIS	3_Yellow_Days	3_Yellow_Days
.	O	O
NO	O	O
PERICARDIAL	O	O
EFFUSION	O	O
IS	O	O
SEEN	O	O
.	O	O
THERE	O	O
IS	O	O
NO	O	O
MASS	O	O
OR	O	O
LYMPHADENOPATHY	O	O
IN	O	O
THE	O	O
MEDIASTINUM	O	O
OR	O	O
PULMONARY	O	O
HILA	O	O
.	O	O
THERE	O	O
IS	O	O
A	O	O
TRACHEOSTOMY	O	O
TUBE	O	O
IN	O	O
PLACE	O	O
.	O	O
THE	O	O
PROMINENCE	O	O
OF	O	O
THE	O	O
RIGHT	O	O
HILAR	O	O
STRUCTURES	O	O
DUE	O	O
TO	O	O
PROMINENT	1_Red_Minutes	O
PULMONARY	1_Red_Minutes	O
ARTERIAL	1_Red_Minutes	O
AND	1_Red_Minutes	O
VENOUS	1_Red_Minutes	O
SYSTEM	1_Red_Minutes	O
.	O	O
POST	O	O
ANASTOMOTIC	O	O
DILATATION	1_Red_Minutes	O
OF	O	O
THE	O	O
PULMONARY	1_Red_Minutes	O
ARTERY	1_Red_Minutes	O
SUGGESTS	O	O
SOME	O	O
DEGREE	O	O
OF	O	O
STENOSIS	1_Red_Minutes	O
AT	1_Red_Minutes	O
THE	1_Red_Minutes	O
LEVEL	1_Red_Minutes	O
OF	1_Red_Minutes	O
THE	1_Red_Minutes	O
ANASTOMOSIS	1_Red_Minutes	O
.	O	O
THERE	O	O
IS	O	O
,	O	O
HOWEVER	O	O
,	O	O
NO	O	O
SIGNS	O	O
OF	O	O
PSEUDOANEURYSM	O	O
,	O	O
EXTRAVASATION	O	O
OR	O	O
HEMATOMA	O	O
AT	O	O
THIS	O	O
LEVEL	O	O
.	O	O
THERE	O	O
IS	O	O
A	O	O
PERSISTENT	3_Yellow_Days	3_Yellow_Days
MODERATE	3_Yellow_Days	3_Yellow_Days
LEFT	3_Yellow_Days	3_Yellow_Days
PLEURAL	3_Yellow_Days	3_Yellow_Days
EFFUSION	3_Yellow_Days	3_Yellow_Days
,	O	O
LEFT	O	O
LOWER	O	O
LOBE	O	O
ATELECTASIS	O	O
AND	O	O
MARKED	3_Yellow_Days	O
CENTRILOBULAR	3_Yellow_Days	3_Yellow_Days
EMPHYSEMA	3_Yellow_Days	3_Yellow_Days
IN	O	O
THE	O	O
AERATED	O	O
PORTION	O	O
OF	O	O
THE	O	O
LEFT	O	O
LUNG	O	O
.	O	O
PERSISTENT	O	O
PARTIAL	O	O
ATELECTASIS	O	O
OF	O	O
THE	O	O
RIGHT	O	O
LOWER	O	O
LOBE	O	O
,	O	O
AND	O	O
PERSISTENT	3_Yellow_Days	O
GROUND	3_Yellow_Days	O
GLASS	3_Yellow_Days	O
OPACITIES	3_Yellow_Days	O
IN	3_Yellow_Days	O
THE	3_Yellow_Days	O
UPPER	3_Yellow_Days	O
RIGHT	3_Yellow_Days	O
LUNG	3_Yellow_Days	O
.	O	O
THERE	O	O
HAS	O	O
BEEN	O	O
DECREASE	3_Yellow_Days	O
IN	3_Yellow_Days	O
THE	3_Yellow_Days	O
AMOUNT	3_Yellow_Days	1_Red_Minutes
OF	3_Yellow_Days	1_Red_Minutes
ASCITES	3_Yellow_Days	1_Red_Minutes
IN	3_Yellow_Days	O
THE	3_Yellow_Days	O
PERIHEPATIC	3_Yellow_Days	O
REGION	3_Yellow_Days	O
.	O	O
THERE	O	O
IS	O	O
AN	O	O
ACUTE	1_Red_Minutes	3_Yellow_Days
DVT	1_Red_Minutes	3_Yellow_Days
IN	1_Red_Minutes	3_Yellow_Days
THE	1_Red_Minutes	3_Yellow_Days
COMMON	1_Red_Minutes	3_Yellow_Days
FEMORAL	1_Red_Minutes	3_Yellow_Days
VEIN	1_Red_Minutes	3_Yellow_Days
SLIGHTLY	O	3_Yellow_Days
EXTENDING	O	O
INTO	O	O
THE	O	O
SUPERFICIAL	1_Red_Minutes	O
FEMORAL	1_Red_Minutes	O
VEIN	1_Red_Minutes	O
ON	1_Red_Minutes	O
THE	1_Red_Minutes	O
RIGHT	1_Red_Minutes	O
SIDE	O	O
AND	O	O
ALSO	O	O
IN	O	O
THE	O	O
PROFUNDA	1_Red_Minutes	O
FEMORAL	1_Red_Minutes	O
VEIN	1_Red_Minutes	O
ON	1_Red_Minutes	O
THE	1_Red_Minutes	O
LEFT.THERE	O	O
IS	O	O
MILD	O	3_Yellow_Days
SUBCUTANEOUS	O	3_Yellow_Days
EDEMA	O	3_Yellow_Days
OF	O	O
BOTH	O	O
LEGS	O	O
.	O	O
THERE	O	O
IS	O	O
UNCHANGED	O	O
DIFFUSE	O	O
OSTEOPENIA	O	O
,	O	O
CHANGES	O	O
POST-RIGHT	O	O
THORACOTOMY	O	O
AND	O	O
MULTIPLE	O	O
OLD	O	O
RIB	O	O
FRACTURES	O	O
ON	O	O
BOTH	O	O
SIDES	O	O
OF	O	O
THE	O	O
THORACIC	O	O
CAGE	O	O
.	O	O
1	O	O
.	O	O
NEGATIVE	O	O
STUDY	O	O
FOR	O	O
ACUTE	O	O
OR	O	O
CHRONIC	O	O
PULMONARY	O	O
EMBOLISM	O	O
.	O	O
SIGNS	O	O
OF	O	O
ACUTE	1_Red_Minutes	O
DEEP	1_Red_Minutes	O
VENOUS	1_Red_Minutes	O
THROMBOSIS	1_Red_Minutes	O
INVOLVING	1_Red_Minutes	O
THE	1_Red_Minutes	O
RIGHT	1_Red_Minutes	O
COMMON/SUPERFICIAL	1_Red_Minutes	O
FEMORAL	1_Red_Minutes	O
VEIN	1_Red_Minutes	O
ON	1_Red_Minutes	O
THE	1_Red_Minutes	O
RIGHT	1_Red_Minutes	O
AND	O	O
PROFUNDA	O	O
FEMORAL	O	O
VEIN	O	O
ON	O	O
THE	O	O
LEFT	O	O
.	O	O
2	O	O
.	O	O
PROMINENT	O	O
RIGHT	O	O
HILUM	O	O
SECONDARY	O	O
TO	O	O
PROMINENCE	O	O
OF	O	O
THE	O	O
VASCULAR	O	O
STRUCTURES	O	O
INCLUDING	O	O
ARTERIES	O	O
AND	O	O
VEINS	O	O
.	O	O
THE	O	O
POSSIBILITY	1_Red_Minutes	O
OF	1_Red_Minutes	O
MILD	1_Red_Minutes	O
STENOSIS	1_Red_Minutes	O
AT	1_Red_Minutes	O
THE	1_Red_Minutes	O
ANASTOMOSIS	1_Red_Minutes	O
OF	1_Red_Minutes	O
THE	1_Red_Minutes	O
RIGHT	1_Red_Minutes	1_Red_Minutes
PULMONARY	1_Red_Minutes	1_Red_Minutes
ARTERY	1_Red_Minutes	1_Red_Minutes
IS	O	O
RAISED	O	O
.	O	O
3	O	O
.	O	O
PERSISTENT	3_Yellow_Days	3_Yellow_Days
DIFFUSE	3_Yellow_Days	3_Yellow_Days
HAZINESS	3_Yellow_Days	3_Yellow_Days
OF	3_Yellow_Days	O
THE	3_Yellow_Days	O
RIGHT	3_Yellow_Days	O
LUNG	3_Yellow_Days	O
,	O	O
WHICH	O	O
COULD	O	O
BE	O	O
RELATED	O	O
TO	O	O
CHRONIC	3_Yellow_Days	O
ATELECTASIS	3_Yellow_Days	O
.	O	O
4	O	O
.	O	O
PERSISTENT	O	O
BIBASILAR	O	O
PARTIAL	O	O
ATELECTASIS	O	O
,	O	O
ESPECIALLY	O	O
ON	O	O
THE	O	O
LEFT	O	O
SIDE	O	O
,	O	O
5	O	O
.	O	O
UNCHANGED	O	O
LEFT	3_Yellow_Days	O
PLEURAL	3_Yellow_Days	O
EFFUSION	3_Yellow_Days	O
,	3_Yellow_Days	O
ATELECTASIS	3_Yellow_Days	O
AND	3_Yellow_Days	O
EMPHYSEMA	3_Yellow_Days	3_Yellow_Days
IN	3_Yellow_Days	O
THE	3_Yellow_Days	O
NATIVE	3_Yellow_Days	O
LUNG	3_Yellow_Days	O
.	O	O
6	O	O
.	O	O
DECREASED	3_Yellow_Days	O
ASCITES	3_Yellow_Days	O
.	O	O
+	O	O
EXAMINATION	O	O
REVIEWED	O	O
&	O	O
REPORTED	O	O
FINDINGS	O	O
CONFIRMED	O	O
BY	O	O
:	O	O
-LSB-	O	O
doctor	O	O
-RSB-	O	O
.	O	O

